These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18096386)

  • 21. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
    Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Chen HS; Tong X; Tong V; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Zhang B; Roy S; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5314-20. PubMed ID: 19682899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.
    Svensson L; Redvall E; Johnsson M; Stenfeldt AL; Dahlgren C; Wennerås C
    J Leukoc Biol; 2009 Aug; 86(2):327-36. PubMed ID: 19414538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonist.
    Zheng X; Hodgetts KJ; Brielmann H; Hutchison A; Burkamp F; Brian Jones A; Blurton P; Clarkson R; Chandrasekhar J; Bakthavatchalam R; De Lombaert S; Crandall M; Cortright D; Blum CA
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5217-21. PubMed ID: 16870426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.
    Santella JB; Gardner DS; Duncia JV; Wu H; Dhar M; Cavallaro C; Tebben AJ; Carter PH; Barrish JC; Yarde M; Briceno SW; Cvijic ME; Grafstrom RR; Liu R; Patel SR; Watson AJ; Yang G; Rose AV; Vickery RD; Caceres-Cortes J; Caporuscio C; Camac DM; Khan JA; An Y; Foster WR; Davies P; Hynes J
    J Med Chem; 2014 Sep; 57(18):7550-64. PubMed ID: 25101488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors.
    Bruno O; Brullo C; Bondavalli F; Schenone S; Spisani S; Falzarano MS; Varani K; Barocelli E; Ballabeni V; Giorgio C; Tognolini M
    Bioorg Med Chem; 2009 May; 17(9):3379-87. PubMed ID: 19362486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR3 antagonists: a survey of the patent literature.
    Gong L; Wilhelm RS
    Expert Opin Ther Pat; 2009 Aug; 19(8):1109-32. PubMed ID: 19637977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
    Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
    Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR3 antagonist impairs estradiol-induced eosinophil migration to the uterus in ovariectomized mice.
    Araújo JMD; Silva LAS; Felix FB; Camargo EA; Grespan R
    Braz J Med Biol Res; 2020; 53(1):e8659. PubMed ID: 31859912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-based molecular design of 4-benzylpiperidinealkylureas and amides as CCR3 antagonists.
    Jain V; Pandey A; Gupta S; Mohan CG
    J Mol Model; 2010 Apr; 16(4):669-76. PubMed ID: 19960358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.
    Kriegl JM; Martyres D; Grundl MA; Anderskewitz R; Dollinger H; Rast G; Schmid B; Seither P; Tautermann CS
    Bioorg Med Chem Lett; 2015 Jan; 25(2):229-35. PubMed ID: 25497216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists.
    Nitta A; Iura Y; Inoue H; Sato I; Morihira K; Kubota H; Morokata T; Takeuchi M; Ohta M; Tsukamoto S; Imaoka T; Takahashi T
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6876-81. PubMed ID: 23046963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of CCR3/H1 dual antagonists with reduced hERG risk.
    Bahl A; Barton P; Bowers K; Brough S; Evans R; Luckhurst CA; Mochel T; Perry MW; Rigby A; Riley RJ; Sanganee H; Sisson A; Springthorpe B
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6688-93. PubMed ID: 23031591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.
    Klinkhammer W; Müller H; Globisch C; Pajeva IK; Wiese M
    Bioorg Med Chem; 2009 Mar; 17(6):2524-35. PubMed ID: 19250834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
    Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel orally active ureido NPY Y5 receptor antagonists.
    Li G; Stamford AW; Huang Y; Cheng KC; Cook J; Farley C; Gao J; Ghibaudi L; Greenlee WJ; Guzzi M; van Heek M; Hwa JJ; Kelly J; Mullins D; Parker EM; Wainhaus S; Zhang X
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1146-50. PubMed ID: 18160282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
    Gomtsyan A; Bayburt EK; Schmidt RG; Surowy CS; Honore P; Marsh KC; Hannick SM; McDonald HA; Wetter JM; Sullivan JP; Jarvis MF; Faltynek CR; Lee CH
    J Med Chem; 2008 Feb; 51(3):392-5. PubMed ID: 18183945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.